Fischer MA, Kesselheim AS, Lu Z, Ross KM, Tessema FA, Avorn J - Journal of Managed Care & Specialty Pharmacy
Most physicians surveyed (55%) acknowledged that step therapy policies could improve medication affordability and clinical appropriateness (59%), though 70% reported interactions with the pharmaceutical industry and subspecialists held more negative views of these utilization management strategies. While physicians recognized the potential benefits of step therapy for cost-effectiveness, they expressed significant concerns about inefficient and inflexible implementation that often failed to account for patient-specific information, suggesting that improved policy design and execution could enhance physician acceptance and compliance.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine